Parametric MR dynamic imaging for breast lesions characterization and prediction of lymph nodes involvement(294 views visite) Ciarmiello A, Gaeta MC, Meniconi M, Milano A, Alfano B, Del Vecchio S, Salvatore M
Keywords Parole chiave: Breast Neoplasms, Contrast Enhancement, Kinetic Studies, Magnetic Resonance (mr), Gadolinium Pentetate Meglumine, Adult, Article, Axillary Lymph Node, Breast Carcinoma, Breast Lesion, Differential Diagnosis, Drug Distribution, Female, Histopathology, Human, Human Tissue, Image Analysis, Major Clinical Study, Nuclear Magnetic Resonance Imaging, Nuclear Magnetic Resonance Scanner, Priority Journal, Contrast Medium, Breast Tumor, Diagnostic Use, Diffusion Weighted Imaging, Evaluation Study, Image Enhancement, Lymphatic Metastasis, Middle Aged, Predictive Value, Procedures, Reproducibility, Sensitivity And Specificity, Diffusion Magnetic Resonance Imaging, Gadolinium Dtpa, Predictive Value Of Tests, Reproducibility Of Results,
Affiliations Affiliazioni: *** IBB - CNR ***
Nuclear Medicine Department, S. Andrea HospitalLa Spezia, Italy Oncology Department, S. Andrea HospitalLa Spezia, Italy Institute of Biostructure and Bioimaging, National Research Council of ItalyNapoli, Italy Department of Advanced Biomedical Sciences, University of Naples Federico IINaples, Italy IRCCS SDNNaples, Italy IRCCS SDN, Naples, Italy
References Riferimenti: Yabuuchi, H., Matsuo, Y., Okafuji, T., Kamitani, T., Soeda, H., Setoguchi, T., Sakai, S., Honda, H., Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images (2008) J. Magn. Reson. Imaging, 28 (5), pp. 1157-116
Kuhl, C.K., Schild, H.H., Dynamic image interpretation of MRI of the breast (2000) J. Magn. Reson. Imaging, 12 (6), pp. 965-974
Hylton, N., MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy (2006) Magn. Reson. Imaging Clin. N. Am, 14 (3), pp. 383-389. , 7
Woodhams, R., Kakita, S., Hata, H., Iwabuchi, K., Kuranami, M., Gautam, S., Hatabu, H., Mountford, C., Identification of residual breast carcinoma following neoadjuvant chemotherapy: Diffusion-weighted imaging- -comparison with contrast-enhanced MR imaging and pathologic findings (2010) Radiology, 254 (2), pp. 357-366
Fahmy, R.G., Dass, C.R., Sun, L.Q., Chesterman, C.N., Khachigian, L.M., Transcription factor Egr-1 supports FGFdependent angiogenesis during neovascularization and tumor growth (2003) Nat. Med, 9 (8), pp. 1026-1032
Horak, E.R., Leek, R., Klenk, N., Lejeune, S., Smith, K., Stuart, N., Greenall, M., Harris, A.L., Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer (1992) Lancet, 340 (8828), pp. 1120-1124
Weidner, N., Semple, J.P., Welch, W.R., Folkman, J., Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma (1991) N. Engl. J. Med, 324 (1), pp. 1-8
Folkman, J., What is the evidence that tumors are angiogenesis dependent (1990) J. Natl. Cancer Inst, 82 (1), pp. 4-6
Hylton, N., Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker (2006) J. Clin. Oncol, 24 (20), pp. 3293-3298
Bhooshan, N., Giger, M.L., Jansen, S.A., Li, H., Lan, L., Newstead, G.M., Cancerous breast lesions on dynamic contrastenhanced MR images: Computerized characterization for imagebased prognostic markers (2010) Radiology, 254 (3), pp. 680-690
Kuhl, C.K., Mielcareck, P., Klaschik, S., Leutner, C., Wardelmann, E., Gieseke, J., Schild, H.H., Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? (1999) Radiology, 211 (1), pp. 101-110
Stack, J.P., Redmond, O.M., Codd, M.B., Dervan, P.A., Ennis, J.T., Breast disease: Tissue characterization with Gd-DTPA enhancement profiles (1990) Radiology, 174 (2), pp. 491-494
Gribbestad, I.S., Nilsen, G., Fjosne, H.E., Kvinnsland, S., Haugen, O.A., Rinck, P.A., Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography (1994) J. Magn. Reson. Imaging, 4 (3), pp. 477-480
Orel, S.G., Schnall, M.D., Livolsi, V.A., Troupin, R.H., Suspicious breast lesions: MR imaging with radiologic-pathologic correlation (1994) Radiology, 190 (2), pp. 485-493
Orel, S.G., Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: Are time-signal intensity curves an accurate predictor? (1999) Radiology, 211 (1), pp. 5-7
Black, M.M., Speer, F.D., Nuclear structure in cancer tissues (1957) Surg. Gynecol. Obstet, 105 (1), pp. 97-102
Ciarmiello, A., Brunetti, A., Larobina, M., Quarantelli, M., Ziviello, M., Alfano, B., Salvatore, M., Assessment of scanner performance and normalization of estimated relaxation rate values (2001) Magn. Reson. Imaging, 19 (1), pp. 123-128
Parker, G.J., Suckling, J., Tanner, S.F., Padhani, A.R., Revell, P.B., Husband, J.E., Leach, M.O., Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics (1997) J. Magn. Reson. Imaging, 7 (3), pp. 564-574
Hittmair, K., Gomiscek, G., Langenberger, K., Recht, M., Imhof, H., Kramer, J., Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI (1994) Magn. Reson. Med, 31 (5), pp. 567-571
Strich, G., Hagan, P.L., Gerber, K.H., Slutsky, R.A., Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA (1985) Radiology, 154 (3), pp. 723-726
Alfano, B., Brunetti, A., Arpaia, M., Ciarmiello, A., Covelli, E.M., Salvatore, M., Multiparametric display of spin-echo data from MR studies of brain (1995) J. Magn. Reson. Imaging, 5 (2), pp. 217-225
Hanley, J.A., McNeil, B.J., The meaning and use of the area under a receiver operating characteristic (ROC) curve (1982) Radiology, 143 (1), pp. 29-36
Flickinger, F.W., Allison, J.D., Sherry, R.M., Wright, J.C., Differentiation of benign from malignant breast masses by timeintensity evaluation of contrast enhanced MRI (1993) Magn. Reson. Imaging, 11 (5), pp. 617-620
Kaiser, W.A., Zeitler, E., MR imaging of the breast: Fast imaging sequences with and without Gd- DTPA. Preliminary observations (1989) Radiology, 170 (3), pp. 681-686
Turkat, T.J., Klein, B.D., Polan, R.L., Richman, R.H., Dynamic MR mammography: A technique for potentially reducing the biopsy rate for benign breast disease (1994) J. Magn. Reson. Imaging, 4 (4), pp. 563-568
Mussurakis, S., Buckley, D.L., Drew, P.J., Fox, J.N., Carleton, P.J., Turnbull, L.W., Horsman, A., Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours (1997) Clin. Radiol, 52 (7), pp. 516-526
Tofts, P.S., Berkowitz, B., Schnall, M.D., Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model (1995) Magn. Reson. Med, 33 (4), pp. 564-568
Liney, G.P., Gibbs, P., Hayes, C., Leach, M.O., Turnbull, L.W., Dynamic contrast-enhanced MRI in the differentiation of breast tumors: User-defined versus semi-automated region-of-interest analysis (1999) J. Magn. Reson. Imaging, 10 (6), pp. 945-949
Baltzer, P.A., Vag, T., Dietzel, M., Beger, S., Freiberg, C., Gajda, M., Camara, O., Kaiser, W.A., Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer (2010) Eur. Radiol, 20 (7), pp. 1563-1571
Chang, Y.W., Kwon, K.H., Choi, D.L., Lee, D.W., Lee, M.H., Lee, H.K., Yang, S.B., Seo, D.Y., Magnetic resonance imaging of breast cancer and correlation with prognostic factors (2009) Acta Radiol, 50 (9), pp. 990-998
Buadu, L.D., Murakami, J., Murayama, S., Hashiguchi, N., Sakai, S., Masuda, K., Toyoshima, S., Ohno, S., Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis (1996) Radiology, 200 (3), pp. 639-649
Parametric MR dynamic imaging for breast lesions characterization and prediction of lymph nodes involvement
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(227 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(287 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(427 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(248 visite) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 DettagliEsporta in BibTeXEsporta in EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(432 visite) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 DettagliEsporta in BibTeXEsporta in EndNote